BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2503055)

  • 1. gamma-Acetylenic-gamma-aminobutyrate as an enzyme-activated inhibitor of D-amino acid transaminase.
    Martinez del Pozo A; Ueno H; Merola M; Danzin C; Manning JM
    Biochimie; 1989 Apr; 71(4):505-8. PubMed ID: 2503055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-induced inactivation of transminases by acetylenic and vinyl analogues of 4-aminobutyrate.
    John RA; Jones ED; Fowler LJ
    Biochem J; 1979 Feb; 177(2):721-8. PubMed ID: 435262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased alanine aminotransferase activity in serum of man during gamma-acetylenic-GABA treatment.
    Olsen R; Hørder M
    Scand J Clin Lab Invest; 1980 Jun; 40(4):393-5. PubMed ID: 7414257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A kinetic model for the action of the enzyme activated irreversible inhibitor 4-amino-5-hexynoic acid in vivo.
    Carney IT; Miller SA; Basford JM; John RA
    Biochem Pharmacol; 1984 Dec; 33(23):3765-9. PubMed ID: 6508832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of pyridoxal phosphate enzymes by gabaculine. Correlation with enzymic exchange of beta-protons.
    Soper TS; Manning JM
    J Biol Chem; 1982 Dec; 257(23):13930-6. PubMed ID: 7142186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of gamma-acetylenic GABA, an enzyme-activated irreversible inhibitor of GABA-transaminase, on dopamine pathways of the extrapyramidal and limbic systems.
    Palfreyman MG; Huot S; Lippert B; Schechter PJ
    Eur J Pharmacol; 1978 Aug; 50(4):325-36. PubMed ID: 699960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gamma-vinyl GABA, and GABA and beta-alanine transamination.
    Lancet; 1984 Mar; 1(8379):737-8. PubMed ID: 6143066
    [No Abstract]   [Full Text] [Related]  

  • 8. Inactivation of dimeric D-amino acid transaminase by a normal substrate through formation of an unproductive coenzyme adduct in one subunit.
    Martinez del Pozo A; Yoshimura T; Bhatia MB; Futaki S; Manning JM; Ringe D; Soda K
    Biochemistry; 1992 Jul; 31(26):6018-23. PubMed ID: 1627544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain.
    Lippert B; Metcalf BW; Jung MJ; Casara P
    Eur J Biochem; 1977 Apr; 74(3):441-5. PubMed ID: 856582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple effects of repeated administration of gamma-acetylenic GABA on rat brain metabolism.
    Rumigny JF; Maitre M; Recasens M; Blindermann JM; Mandel P
    Biochem Pharmacol; 1981 Feb; 30(4):305-12. PubMed ID: 7213420
    [No Abstract]   [Full Text] [Related]  

  • 11. Inactivation of bacterial D-amino acid transaminase by beta-chloro-D-alanine.
    Soper TS; Jones WM; Lerner B; Trop M; Manning JM
    J Biol Chem; 1977 May; 252(10):3170-5. PubMed ID: 863877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different modes of action of inhibitors of bacterial D-amino acid transaminase. A target enzyme for the design of new antibacterial agents.
    Soper TS; Manning JM
    J Biol Chem; 1981 May; 256(9):4263-8. PubMed ID: 7217082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gamma-acetylenic GABA and gamma-vinyl GABA on synaptosomal release and uptake of GABA.
    Abdul-Ghani AS; Norris PJ; Smith CC; Bradford HF
    Biochem Pharmacol; 1981 Jun; 30(11):1203-9. PubMed ID: 7271818
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereospecificity of reactions catalyzed by bacterial D-amino acid transaminase.
    Martínez del Pozo A; Merola M; Ueno H; Manning JM; Tanizawa K; Nishimura K; Soda K; Ringe D
    J Biol Chem; 1989 Oct; 264(30):17784-9. PubMed ID: 2808352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation of the properties of ornithine aminotransferase after inactivation by the 'suicide' inhibitor aminohexynoate and use of the compound as a probe of intracellullar protein turnover.
    Jones ED; Basford JM; John RA
    Biochem J; 1983 Jan; 209(1):243-9. PubMed ID: 6847611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible inhibitors of GABA transaminase induce antinociceptive effects and potentiate morphine.
    Buckett WR
    Neuropharmacology; 1980 Aug; 19(8):715-22. PubMed ID: 7191489
    [No Abstract]   [Full Text] [Related]  

  • 17. Inactivation of bacterial D-amino acid transaminases by the olefinic amino acid D-vinylglycine.
    Soper TS; Manning JM; Marcotte PA; Walsh CT
    J Biol Chem; 1977 Mar; 252(5):1571-5. PubMed ID: 402367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of an irreversible inhibitor (RMI71645) of gamma-aminobutyric acid (GABA) transaminase on spontaneous and conditioned activities of mice].
    Misslin R; Hinschberger A; Ropartz P; Mandel P
    C R Acad Hebd Seances Acad Sci D; 1976 Oct; 283(10):1221-4. PubMed ID: 827360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial reactions of bacterial D-amino acid transaminase with asparagine substituted for the lysine that binds coenzyme pyridoxal 5'-phosphate.
    Yoshimura T; Bhatia MB; Manning JM; Ringe D; Soda K
    Biochemistry; 1992 Dec; 31(47):11748-54. PubMed ID: 1445909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-activated inhibition of bacterial D-amino acid transaminase by beta-cyano-D-alanine.
    Ueno H; Soper TS; Manning JM
    Biochem Biophys Res Commun; 1984 Jul; 122(2):485-91. PubMed ID: 6466323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.